Kava Root Extract Market Key Players Analysis, Emerging Opportunities, Competitive Landscape and Forecast to 2029

The global kava root extract market size is predicted to hit USD 3.41 billion in 2029 and exhibit a CAGR of 16.29% during the forecast period. The swiftly expanding supplements industry and the increasing kava root extract incorporation in the pharmaceutical industry are anticipated to bolster the market expansion. Fortune Business InsightsTMhas presented this information in its report titled, “Kava Root Extract Market, 2022-2029”. The market size stood at USD 1.02 billion in 2021 and USD 1.18 billion in 2022.

Further, the rising acceptance of herbal extracts infused non-alcoholic beverages is estimated to favor the market’s expansion.

List of Key Industry Players-

Botanic Healthcare (India)
NOW Health Group Inc. (U.S.)
Gaia Herbs Inc. (U.S.)
Root of Happiness (U.S.)
LifeSeasons, Inc. (U.S.)
Natural Factors Nutritional Products Ltd. (U.S.)
Best Nutrition Product, Inc. (U.S.)
Fiji Kava Australia Ltd. (Australia)
Kona Kava Farm (U.S.)
Nutragreenlife Biotechnology Co., Ltd. (China)
Drivers & Restraints-

Rising Functional Food Consumption to Fuel Market Growth

Kava root extract’s therapeutic and relaxing properties have escalated its demand for applications in several personal care and pharmaceutical products. It is widely consumed by Western population as tablets or capsules containing acetonic or ethanolic extracts. The consumption of the extract has witnessed a substantial increase in consumption as a dietary supplement. The rising popularity of herbal extracts-infused non-alcoholic beverages due to mushrooming health awareness is predicted to complement the kava root extract market growth.

Moreover, the growing consumption and demand for these extracts by the pharmaceutical industry due to their therapeutic and relaxing properties is anticipated to favor market growth. The swiftly expanding supplements industry due to a heightened consumption by the geriatric population is estimated to foster the growth of the market. Additionally, the rising functional food consumption is anticipated to benefit the market’s expansion due to proliferated demand for kava in functional beverages and foods.

However, raw material price fluctuations and low market penetration may restrain the market’s expansion during the forecast period.

Regional Insights-

High Production and Consumption of Kava to Boost Growth in Fiji

Fiji is a prominent consumer and producer of kava root extracts and is predicted to attain a humongous global kava root extract market share. The country is the largest producer of this extract and the favorable initiatives for unemployed rural individuals and farmers are projected to bolster the market’s expansion in Fiji.

Vanuatu is anticipated to exhibit substantial growth in the coming years. Factors such as the rising demand for nutritional supplements, urbanization, a surge in women kava drinkers, and an ever-increasing populace are expected to stimulate the market growth in the country.

The evolving consumption patterns are predicted to escalate product consumption and flourish in growth in the U.S.

Competitive Landscape-

Key Players Launch New Products to Amplify their Global Positions

The major players operating in the market emphasize upgrading current product portfolios by incorporating advanced technologies to enhance their offerings. The major market players adopt ingenious strategies, including contracts, acquisitions, mergers, collaborations, and others to amplify their growth prospects. For instance, a pre-packaged kava drink, Drink Leilo, was launched in the U.S. in March 2020.

Key Industry Development-

March 2022: HiLands Foods and Lami Kava partnered to launch premium quality kava root herbal extract in the Australian market. The partnership is aimed to fortify distribution networks and presence of the two companies across the country.
Browse In-depth Summary of This Research Insight:

https://www.fortunebusinessinsights.com/kava-root-extract-market-103694

Propaganda and Distribution, in its entirety, is the PCD Full Form. In the pharmaceutical industry, PCD is used for marketing and distribution rights. In essence, PCD (Propaganda cum Distribution) is a franchising business. Let us look at what is meant by a franchise business. When a company allows a person or another company to sell its products under its own name. It is referred to as franchising a business. The franchise upholds the principles and standards of conduct supported by the company that authorizes it.
Visit: https://www.aviotichealthcare.com/pcd-full-form/

Seamless Pipes at Best Price in India

With the help of a team of professionals with a lot of experience, we Seamless Pipe Dealer trade and sell high-quality Seamless Pipe. Chemical plants, oil and gas companies, railroad coaches, and the pharmaceutical industry all use these pipes a lot. All of the pipes we sell, such as Seamless Pipes, MS Round Pipe, GI Pipes, etc., are made by reputable sellers in the market who use the best quality raw metals. Our pipes have a longer shelf life, a smooth finish, a compact design, resistance to corrosion, and other features. We can get these pipes in a wide range of sizes, grades, standards, and dimensions to meet our clients' exact needs. We sell the most seamless pipe at a fair price and are the largest dealer of it. We are one of the best places in India to buy ms pipes.
Visit more:- https://jrspipesandtubes.com/seamless-pipe-dealers/

Online Medicine USA Nowadays, the world is seeing a big demand for medicines. Similarly, the rapid demand for #medicineintheUSA has increased in recent years. This is a big challenge for the pharmaceutical industry to fulfill
the needs of drugs in the USA. But, apart from challenges, it also gives an opportunity to all
interested pharmaceutical companies to increase their business. Industries and online
pharmacy stores also increase to meet the client’s demand. It is necessary to make society healthy
and keep at bay harmful diseases that may damage one’s body.
But, as we know, certain medicines also fall under the category of controlled substances, which
increases the chances of addiction. So, one should accept these medicines only under the guidance
of medical experts. You should be strict with the exact dosage to have a positive result. Neither
lower nor increase its dosage frequently without consulting with a doctor because it may create
withdrawal symptoms in the client’s body. To get detailed information, go to Medlypharmacareusa.

https://medlypharmacareusa.com/

The global Flavors into Over-The-Counter (OTC) Pharmaceuticals market was valued at USD 3.45 billion in 2022 and expected to grow at a CAGR of 6.5% during the forecast period. Flavors are substances that are used to alter the taste and smell of products. In the pharmaceutical industry, flavors are commonly used to improve the taste and odor of over-the-counter (OTC) medications. OTC medications are drugs that can be purchased without a prescription and are commonly used to treat minor ailments such as cold and flu symptoms, headaches, and allergies

Read More: https://wemarketresearch.com/reports/flavors-into-over-the-counter-(otc)-pharmaceuticals-market/432/

The global Tocopherol Mix market was valued at USD 1.45 billion in 2022 and expected to grow at a CAGR of 5.3% during the forecast period. Tocopherol mix is a combination of four types of tocopherols - alpha, beta, gamma, and delta tocopherols. Tocopherols are fat-soluble compounds and are part of the vitamin E family. Tocopherol mix is commonly used in the food industry as a natural antioxidant to prevent lipid oxidation in various food products. It is also used in the cosmetic and personal care industries as an active ingredient in various skincare products due to its antioxidant properties that protect the skin from damage caused by free radicals. Tocopherol mix is also used in the pharmaceutical industry for its potential health benefits.

Read More: https://wemarketresearch.com/reports/tocopherol-mix-market/429/

Masterbatch Industry Growth& Forecast Report by 2026

The global masterbatch industry size is likely to reach USD 16.35 billion by 2026 owing to the rising number of building and construction activities worldwide. Masterbatches are liquid

Browse Detailed Summary of Research Report:

https://www.fortunebusinessinsights.com/masterbatch-market-102353

https://www.globenewswire.com/en/news-release/2022/06/15/2462849/0/en/With-5-3-CAGR-Masterbatches-Market-to-Hit-USD-16-35-Billion-by-2026-Rise-in-Demand-for-Plastic-from-Pharmaceutical-Industry-for-Packaging-will-Bolster-Growth.html

According to Fortune Business Insights™, the global zinc oxide market size is predicted to reach USD 6.36 billion by 2026, exhibiting a CAGR of 5.7% during the forecast period. The increasing application of zinc oxide in the cosmetic and pharmaceutical industry will contribute positively to the zinc oxide market growth during the forecast period.

Browse Detailed Summary of Research Report:

https://www.fortunebusinessinsights.com/zinc-oxide-market-102480

Pharmaceutical Glass Packaging Market Share, Demand, Analysis, Growth, Size and Forecast 2027
The pharmaceutical glass packaging market is set to gain momentum from the increasing development of new types of glasses owing to the high demand from the pharmaceutical industry. This information is given by Fortune Business Insights™ in a new study, titled, “Pharmaceutical Glass Packaging Market Size, Share & Industry Analysis, By Product (Vials & Ampoules, Bottles, Cartridges, and Syringes), By Drug Type (Generic, Branded, and Biologic), and Regional Forecast, 2020-2027.” The study further mentions that the pharmaceutical glass packaging market size was USD 6.31 billion in 2019 and is projected to reach USD 10.76 billion by 2027, exhibiting a CAGR of 6.3% during the forecast period.

How Did We Create This Report?

As customer expectations are changing, the aspirations of dealers are also transforming rapidly. Distribution channels are becoming complex. To provide our clients with detailed information, we have conducted extensive primary and secondary research. We have thoroughly investigated each opportunity qualitatively and quantitatively so that our clients get a complete picture of both emerging and existing opportunities in the market for pharmaceutical glass packaging. We have also conducted a techno-economic study.

Drivers & Restraints-

Rising Awareness of Health to Favor Growth

The pharmaceutical industry is expanding rapidly across the globe. The rising expenditure on public healthcare systems, increasing awareness of health, and astonishingly surging population are the prime factors for the pharmaceutical glass packaging market growth in the upcoming years. However, the industry is making more usage of plastic packaging nowadays backed by its impact resistance, cost effectiveness, easy molding, and flexibility properties. It may lower the demand for pharmaceutical glass packaging.


Regional Insights-

Increasing Spending on Healthcare to Help North America Remain at the Forefront

Geographically, North America procured USD 2.12 billion in 2019 in terms of revenue. The ongoing expansion of the pharmaceutical industry would propel the regional growth. Besides, the increasing prevalence of various diseases, as well as surging spending on healthcare is likely to propel growth.

Europe, on the other hand, is projected to remain in the second position throughout the forthcoming years on account of the rising government guidelines for controlling the transmission of COVID-19. Italy, Germany, and the U.K. are considered to be the main contributors to this growth. In Latin America, governments are implementing new policies, such as favorable tariff protection. Coupled with this, the increasing geriatric population would accelerate the demand for pharmaceutical glass packaging.


Information Source:

https://www.fortunebusinessinsights.com/pharmaceutical-glass-packaging-market-104710

Allergy Treatment Market Report by Worldwide Market Trends & Opportunities and Forecast to 2028

At 6.9% CAGR, the Global Allergy Treatment Market is anticipated to accumulate US$ 35,812.33 million by 2028, says The Insight Partners
According to The Insight Partners’ research, the global allergy treatment market was valued at US$ 21,160.92 million in 2020 and is projected to expand at a 6.9% CAGR between 2021 and 2028 to amass US$ 35,812.3 million by 2028. Increasing adoption of immunotherapy in allergy treatment and developments in food allergy treatments are the key factors aiding market augmentation.
Immunotherapy is offered in two types—allergy shots and sublingual immunotherapy (SLIT). Allergy shots are the extracts of allergens that are administered with increasing dosage; they are effective for allergies. The administration of a repetitive dosage of allergen makes patients less sensitive to that allergen, thus relieving allergic symptoms. Immunotherapy has shown positive and long-term benefits in allergic patients. Moreover, it is suitable for self-administration and medicine usage in homecare settings. Therefore, immunotherapy has emerged as a safe and effective alternative subcutaneous route for chronic and recurrent allergies. Various studies have shown that immunotherapy reduces allergic symptoms by 60–65% among patients who have completed their dosages of allergen. According to a study published in Annals of Allergy, Asthma and Immunology Journal in February 2016, ~70% of allergy patients do not need medications for their allergic reactions. The study also stated that immunotherapy is effective among children as well as the elderly population. Thus, the increasing adoption of immunotherapy in treating allergies is fueling the allergy treatment market growth.
Allergy is a common medical condition among a large share of the global population. It is one of the chronic health conditions that may result in severe consequences. Food allergies are ubiquitous in North America and Europe. According to the Center for Biologics Evaluation and Research of the Food and Drug Administration (FDA), ~1 million children in the US are allergic to peanuts, and one in five of these children is likely to surmount the respective allergy condition. Therefore, developing treatment options for allergies to such common foodstuff is essential. Pharmaceutical industry developments have enabled companies to offer treatment for peanut allergy reactions. Palforzia was developed by Aimmune Therapeutics, Inc., a Nestle Health Science Company. Such developments in the food allergy treatment options and their effectiveness are boosting the growth of the allergy treatment market.
Based on allergy type, the global allergy treatment market is divided into eye allergy, rhinitis, asthma, skin allergy, food allergies, and other allergies. Among these, the rhinitis segment held 39.06% of the market share in 2020. The segment was assessed at US$ 8,265.45 million in 2020 and is estimated to accumulate US$ 13,701.80 million by 2028, expanding at a 6.6% CAGR over 2021–2028.
As per the end route of administration, the market is arrayed into anti-allergy drugs and immunotherapy. Among these, the anti-allergy segment accounted for 89.88% of the market share in 2020. The segment was valued at US$ 19,018.62 million in 2020 and is anticipated to be worth US$ 31,603.17 million by 2028, growing at a 6.6% CAGR over the analysis timeframe. In May 2020, Stallergenes Greer May-20 Product News Stallergenes Greer, a biopharmaceutical company specializing in treatments for respiratory allergies, announced the expansion of the supply of subcutaneous products (SCIT), further broadening its offering to patients and the medical community through sustained investment in quality and operational excellence.
From the regional frame of reference, North America held a significant share in the global allergy treatment market in 2020. The regional market was valued at US$ 6,646.04 million in 2020 and is projected to be worth US$ 10,940.67 million by 2028. Further, Asia Pacific market is projected to expand at a stellar growth rate of 7.4% CAGR during the forecast period. In October 2017, Stallergenes Greer plc announced the acquisition of Medic Savoure Limited, a well-established allergy immunotherapy (AIT) leader in Canada. The acquisition strengthened Stallergenes Greer’s local presence and accelerated the company’s growth in Canada.
Leading players profiled in the global allergy treatment market report are Johnson and Johnson Services, Inc.; Sanofi; AbbVie Inc. (Allergan plc); Pfizer Inc.; LETIPharma; ALK-Abelló A/S; Allergy Therapeutics; Stallergenes Greer; GlaxoSmithKline plc; and Dermapharm Holding.